Search

Your search keyword '"Katie Jeffery"' showing total 173 results

Search Constraints

Start Over You searched for: Author "Katie Jeffery" Remove constraint Author: "Katie Jeffery"
173 results on '"Katie Jeffery"'

Search Results

1. Genomic epidemiology describes introduction and outbreaks of antifungal drug-resistant Candida auris

2. Retrospective analysis of hospital electronic health records reveals unseen cases of acute hepatitis with unknown aetiology in adults in Oxfordshire

3. The plasmidome associated with Gram-negative bloodstream infections: A large-scale observational study using complete plasmid assemblies

4. Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

5. Author Correction: The plasmidome associated with Gram-negative bloodstream infections: a large-scale observational study using complete plasmid assemblies

6. Molecular epidemiology and antimicrobial resistance phenotype of paediatric bloodstream infections caused by Gram-negative bacteria

7. Rapid escape of new SARS-CoV-2 Omicron variants from BA.2-directed antibody responses

8. Divergent trajectories of antiviral memory after SARS-CoV-2 infection

9. A Hybrid Architecture (CO-CONNECT) to Facilitate Rapid Discovery and Access to Data Across the United Kingdom in Response to the COVID-19 Pandemic: Development Study

10. SARS-CoV-2 antibody responses post-vaccination in UK healthcare workers with pre-existing medical conditions: a cohort study

11. Ten-year longitudinal molecular epidemiology study of Escherichia coli and Klebsiella species bloodstream infections in Oxfordshire, UK

12. Two doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concern

13. Hepatitis B virus (HBV) viral load, liver and renal function in adults treated with tenofovir disoproxil fumarate (TDF) vs. untreated: a retrospective longitudinal UK cohort study

14. T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses

15. T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort study

16. Stringent thresholds in SARS-CoV-2 IgG assays lead to under-detection of mild infections

17. Transmission of community- and hospital-acquired SARS-CoV-2 in hospital settings in the UK: A cohort study.

18. HBV vaccination and PMTCT as elimination tools in the presence of HIV: insights from a clinical cohort and dynamic model

19. Assessing a novel, lab-free, point-of-care test for SARS-CoV-2 (CovidNudge): a diagnostic accuracy study

20. SARS-CoV-2 RNA detected in blood products from patients with COVID-19 is not associated with infectious virus [version 2; peer review: 2 approved]

21. Differential occupational risks to healthcare workers from SARS-CoV-2 observed during a prospective observational study

22. Hepatitis virus (HCV) diagnosis and access to treatment in a UK cohort

23. Oxford Screening CSF and Respiratory samples (‘OSCAR’): results of a pilot study to screen clinical samples from a diagnostic microbiology laboratory for viruses using Illumina next generation sequencing

24. Potential for diagnosis of infectious disease from the 100,000 Genomes Project Metagenomic Dataset: Recommendations for reporting results [version 1; peer review: 2 approved]

25. Electronic Health Informatics Data To Describe Clearance Dynamics of Hepatitis B Surface Antigen (HBsAg) and e Antigen (HBeAg) in Chronic Hepatitis B Virus Infection

26. Validation of Multiplex Serology for human hepatitis viruses B and C, human T-lymphotropic virus 1 and Toxoplasma gondii.

27. Prevalence and Characteristics of Hepatitis B Virus (HBV) Coinfection among HIV-Positive Women in South Africa and Botswana.

28. Prolonged activation of virus-specific CD8+T cells after acute B19 infection.

29. Planning for the emergence of vaccine-resistant SARS-CoV-2: addressing revaccination delivery bottlenecks

30. Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY)

31. Clinical associations with carriage of pulmonary Stenotrophomonas maltophilia

32. 14-year trends and resistance patterns of blood and cerebrospinal fluid cultures in children under three years old

33. High-resolution African HLA resource uncoversHLA-DRB1expression effects underlying vaccine response

34. Impaired antibody response to COVID‐19 vaccination in patients with chronic myeloid neoplasms

35. Hepatitis B virus (HBV) viral load, liver and renal function in adults treated with tenofovir disoproxil fumarate (TDF) vs. untreated: a retrospective longitudinal UK cohort study

36. Constructing custom-made radiotranscriptomic signatures of vascular inflammation from routine CT angiograms: a prospective outcomes validation study in COVID-19

37. Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis

38. Evolution of long-term vaccine induced and hybrid immunity in healthcare workers after different COVID-19 vaccination regimens: a longitudinal observational cohort study

39. Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

40. Ten Years of Population-Level Genomic Escherichia coli and Klebsiella pneumoniae Serotype Surveillance Informs Vaccine Development for Invasive Infections

41. Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum

42. The mobilome associated with Gram-negative bloodstream infections: A large-scale observational hybrid sequencing based study

43. Divergent trajectories of antiviral memory after SARS-CoV-2 infection

44. Nanopore metagenomic sequencing to investigate nosocomial transmission of human metapneumovirus from a unique genetic group among haematology patients in the United Kingdom

45. Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

46. SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses

47. Comparison of two T-cell assays to evaluate T-cell responses to SARS-CoV-2 following vaccination in naïve and convalescent healthcare workers

48. Rapid turnaround multiplex sequencing of SARS-CoV-2: comparing tiling amplicon protocol performance

49. Time of Day of Vaccination Affects SARS-CoV-2 Antibody Responses in an Observational Study of Health Care Workers

50. SARS-CoV-2 antibody responses post-vaccination in UK healthcare workers with pre-existing medical conditions: a cohort study

Catalog

Books, media, physical & digital resources